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Abstract 
 Progesterone Receptor Membrane Component-1 (PGRMC1) is a 35 
highly conserved multifunctional protein that is found in numerous systems, 
including reproductive system. Interestingly, PGRMC1 is expressed at several 
intracellular locations, including the nucleolus. The aim of this study is to 
investigate the functional relationship between PGRMC1 and nucleolus. 
Immunofluorescence experiments confirmed PGRMC1’s nucleolar localization 40 
in bovine granulosa cells (bGC) and oocytes. Additional experiments 
conducted on bGC revealed that PGRMC1 co-localizes with nucleolin, a 
major nucleolar protein. Furthermore, small interfering RNA (RNAi) mediated 
gene-silencing experiments showed that when PGRMC1 expression was 
depleted, nucleolin translocated from the nucleolus to the nucleoplasm. 45 
Although PGRMC1 influenced the localization of nucleolin, a direct interaction 
between these two proteins was not detected using in situ proximity ligation 
assay.  This suggests the involvement of additional molecules in mediating 
the co-localizaton of PGRMC1 and nucleolin.  Since nucleolin translocates 
into the nucleoplasm in response to various cellular stressors, PGRMC1’s 50 
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ability to regulate its localization within the nucleolus is likely an important 
component of mechanism by which cells response to stress.  This concept is 
consistent with PGRMC1’s well-described ability to promote ovarian cell 
survival and provides a rationale for future studies on PGRMC1, nucleolin and 
the molecular mechanism by which these two proteins protect against the 55 
adverse effect of various cellular stressors. 
 
 
Introduction 
 Progesterone Receptor Membrane Component 1 (PGRMC1) is a 60 
widespread and multifunctional protein that is highly conserved in eukaryotes. 
It belongs to the membrane associated progesterone receptor (MAPR) family 
and is expressed in several mammalian organs and tissues (Runko et al. 
1999, Raza et al. 2001, Sakamoto et al. 2004, Bali et al. 2013a, Bali et al. 
2013b), including those of the reproductive system (Zhang et al. 2008, 65 
Luciano et al. 2010, Aparicio et al. 2011, Luciano et al. 2011, Keator et al. 
2012, Saint-Dizier et al. 2012, Tahir et al. 2013, Kowalik et al. 2016). 
Specifically, granulosa and luteal cells of human, rodent, bovine and canine 
ovaries (Engmann et al. 2006, Peluso 2006, Aparicio et al. 2011, Luciano et 
al. 2011, Tahir et al. 2013, Griffin et al. 2014, Terzaghi et al. 2016) as well as 70 
oocytes express PGRMC1 (Luciano et al. 2010, Luciano et al. 2013, Terzaghi 
et al. 2016). 
 Multiple functions are attributed to PGRMC1 (reviewed in (Cahill 2007, 
Brinton et al. 2008, Neubauer et al. 2013, Peluso & Pru 2014, Cahill et al. 
2016, Ryu et al. 2017)) as reflected by it being localized to numerous sub-75 
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cellular compartments.  As predicted by the presence of a transmembrane 
domain, PGRMC1 localizes in several membranous compartments, such as 
the endoplasmic reticulum, the Golgi apparatus, the nuclear and plasma 
membranes, the endosomes, and the secretory vesicles (Meyer et al. 1996, 
Raza et al. 2001, Bramley et al. 2002, Hand & Craven 2003, Shin et al. 2003, 80 
Sakamoto et al. 2004, Min et al. 2005, Peluso et al. 2006, Zhang et al. 2008, 
Neubauer et al. 2009, Ahmed et al. 2010, Roy et al. 2010, Wu et al. 2011, Xu 
et al. 2011, Mir et al. 2012, Mir et al. 2013, Thomas et al. 2014). Interestingly, 
PGRMC1 is also detected in the nucleus (Beausoleil et al. 2004, Peluso et al. 
2008, Zhang et al. 2008, Ahmad et al. 2009, Peluso et al. 2009, Luciano et al. 85 
2010, Peluso et al. 2010a, Peluso et al. 2012), specifically to the nucleolus 
(Ahmad et al. 2009, Luciano et al. 2010, Boisvert et al. 2012, Thul et al. 
2017)] http://www.proteinatlas.org]. This high compartmentalization suggests 
that at each site PGRMC1 participates in the control of precise cellular 
processes.  90 
 In order to shed light into the intricate story of PGRMC1’s biological 
significance, it is important to dissect the function of PGRMC1 at each sub-
cellular compartment. To this end, we have started to address whether 
PGRMC1 has a role in regulating the nucleolar function.  Although the 
nucleolus’ main function involves ribosome subunits production, recent 95 
advances describe it as a multifunctional subnuclear compartment.  It appears 
that the nucleolus is a dynamic structure, which disassembles during mitosis 
and responds to signaling events during interphase.  As such, it is involved in 
cell cycle control, especially regulating protein modifications such as 
sumoylation and phosphorylation or sequestrating specific proteins (Boisvert 100 
 5 
et al. 2007). Furthermore, it acts as a stress sensor mediating p53 
stabilization in order to arrest cell cycle progression (Boisvert et al. 2007, 
Boulon et al. 2010).  Thus, the overall goal of the present study is to examine 
the role of PGRMC1 on nucleolar function, particularly its relationship with 
nucleolin (NCL), a well-characterized nucleolar protein (Boisvert et al. 2007, 105 
Tajrishi et al. 2011).  
 
Material and methods 
 
Reagents 110 
 All the chemicals used in this study were purchased from Sigma-
Aldrich (St. Louis, MO) except for those specifically mentioned. Gene 
silencing was performed by using the Stealth RNAi™ siRNA technology from 
Life Technologies as previously described (Terzaghi et al. 2016) using 
PGRMC1 Stealth RNAi (PGRMC1 RNAi: (RNA)-GAG UUG UAG UCA AGU 115 
GUC UUG GUC U) within the coding region of the bovine PGRMC1 sequence 
(RefSeq: NM_001075133). Negative control (cat n. 12935-200) was chosen 
among the Stealth RNAi negative control (CTRL RNAi) duplexes available 
from Life Technologies, designed to minimize sequence homology to any 
known vertebrate transcript. Primary antibodies used in this study are listed in 120 
Table 1.  
 
Sample collection 
Bovine samples: 
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Ovaries from Holstein dairy cows were recovered at the abattoir (INALCA 125 
S.p.A., Ospedaletto Lodigiano, LO, IT 2270M CE, Italy) from pubertal females 
subjected to routine veterinary inspection and in accordance to the specific 
health requirements stated in Council Directive 89/556/ECC and subsequent 
modifications. Ovaries were transported to the laboratory within 2 hours in 
sterile saline (NaCl, 9 g/l) maintained at 26°C and all subsequent procedures, 130 
unless differently specified, were performed at 35-38°C. Bovine granulosa 
cells (bGC) were collected as previously described (Terzaghi et al. 2016). 
Briefly the content of 2-8 mm ovarian follicles, which typically contain fully-
grown oocytes, was aspirated and cumulus-oocyte complexes (COCs) were 
collected and processed for further immunofluorescence analysis (see below). 135 
Remaining follicular cells were washed in M199 supplemented with HEPES 
20 mM, 1,790 units/L Heparin and 0.4% of bovine serum albumin (M199-D). 
The cell pellet was re-suspended in 1ml of Dulbecco’s modified growth 
medium supplemented with 10% of bovine calf serum, 100 U/ml penicillin G, 
100 µg/ml, Streptomycin and Glutamax 100U/ml (Gibco). The cell suspension 140 
was plated in a 25 cm2 flask with 6 ml of growth medium and incubated in 
humidified air at 37°C with 5% CO2. After 24 hours cells were gently washed 
with PBS and the growth medium was changed. Cells were incubated until 
confluence, then collected after trypsinization and re-plated according to the 
experimental design (see below). 145 
 Oocytes in their growing phase, characterized by a diffuse filamentous 
pattern of chromatin in the nuclear area and the presence of an active 
nucleolus were collected as previously described from 0.5 to <2 mm early 
antral follicles by rupturing the follicle wall under the stereomicroscope (Lodde 
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et al. 2008); Both COCs collected from 0.5 to <2 mm and 2-8 antral follicles 150 
were mechanically denuded using the vortex and fixed for further 
immunofluorescence analysis. 
 
RNAi treatment 
 RNA interference (RNAi) experiments on bGC were conducted as 155 
previously described (Terzaghi et al. 2016). Cells were plated in a total 
number of 2 X 105 bGC cells in 2 ml of medium on cover glasses in 35-mm 
culture dishes and incubated in humidified air at 37°C with 5% CO2. After 24 
h, cells at 50-70% of confluence were transfected with 6 µl of 20 µM PGRMC1 
Stealth RNAi or CTRL RNAi combined with 10 µl of Lipofectamine RNAi MAX 160 
(Life Technologies) in a final volume of 2 ml OPTIMEM (Life Technologies), 
according to the manufacturer protocol, and cultured for 48 h.  
 
Western blot analysis  
 The levels of PGRMC1 protein expression in CTRL and PGRMC1 165 
RNAi treated bGC were assessed by Western blotting assay as previously 
described (Terzaghi et al. 2016). PGRMC1 or CTRL RNAi treated bGC were 
lysed in radioimmunoprecipitation assay (RIPA) buffer [50 mM Tris-HCl (pH 
7.4), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40 (NP-40), and 0.25% 
sodium deoxycolate], supplemented with protease inhibitors and phosphatase 170 
inhibitors. All procedures were conducted on ice. Total amount of protein was 
determined using the Qubit® Protein Assay Kit and Qubit® fluorometer 
(Thermo Fisher Scientific). 20 µg of total protein/lane were used for Western 
blottings. After the run, samples were transferred to nitrocellulose membrane 
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(Bio-Rad), which was then incubated with 5% dry milk powder in TBS 175 
containing 0.1% tween (TBS/T) for 2 hours at room temperature. PGRMC1 
immunodetection was conducted using the rabbit polyclonal antibodies (see 
table 1) in 5% dry milk TBS/T. PGRMC1 was revealed using a stabilized goat 
anti rabbit IgG peroxidase conjugated antibody and detected using the Super 
Signal West Dura Extended Duration Substrate (Thermo Fisher Scientific). 180 
The nitrocellulose membrane was stripped in stripping buffer (100 mM 2-
mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl [pH 6.7]) at 50°C for 30 min 
and re-probed with the anti beta tubulin antibody at dilution 1:1000, which was 
revealed using a stabilized goat anti mouse IgG peroxidase conjugated 
antibody as loading control.  185 
 
Immunofluorescence 
 Immunofluorescence staining was performed on bGC as previously 
described (Lodde & Peluso 2011, Terzaghi et al. 2016). Briefly, cells were 
fixed in 4% paraformaldehyde in PBS for 7 minutes and permeabilized with 190 
0.1% triton-X in PBS for 7 minutes. Samples were blocked with 20% normal 
donkey serum in PBS and incubated overnight at 4°C with the rabbit anti 
PGRMC1 antibody (see table1). Double immunostaining was performed on 
bGC by incubating the samples with the rabbit anti PGRMC1 or the mouse 
anti NCL antibodies or a combination of the two. After incubation with 195 
secondary antibodies for 1 h at room temperature, samples were washed and 
finally mounted on slides in the antifade medium Vecta Shield (Vector 
Laboratories) supplemented with 1 µg/ml 40,6-diamidino-2-phenylindole 
(DAPI). Immunofluorescent analysis on bovine oocytes were performed as 
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previously described (Luciano et al. 2010) on 4% paraformaldehyde fixed 200 
oocytes. Immunofluorescent staining was performed as described for bGC 
with the exception that oocytes were fixed for 30 min at room temperature 
followed by 30 min and permeabilized with 0.3% Triton-X 100 for 10 minutes.  
 bGC and oocytes were analyzed on an epifluorescence microscope 
(Eclipse E600; Nikon) equipped with a 40 X and a 60X objective, a digital 205 
camera (Nikon digital sight, DS-U3) and software (NIS elements Imaging 
Software; Nikon). Immunofluorescence negative controls, which were 
performed by omitting one or both the primary antibodies, did not show any 
staining under the same exposure settings. Images that were used for image 
quantification analysis were captured under the same settings. 210 
 
In situ Proximity Ligation Assay (PLA) 
 In situ Proximity Ligation Assay (PLA; Duolink® SIGMA) was used to 
assess the interaction between PGRMC1 and nucleolin in bGC following 
following the manufacturer protocol. Primary antibodies for PGRMC1 and 215 
nucleolin were the same used for immunofluorescence, while anti-rabbit 
PLUS and anti-mouse MINUS PLA probes were used as secondary 
antibodies. Negative controls were performed omitting one of the two primary 
antibodies. Cells were mounted with Duolink mounting medium. 
 220 
Image analysis 
 Quantification of Fluorescent Intensity (FI) signal was performed using 
the ImageJ software (https://imagej.net). The nucleolar signal of PGRMC1 in 
bGC was quantified calculating the integrated density of PGRMC1 signal 
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selecting the whole PGRMC1 positive areas in the nucleus of a total of 50 225 
cells for each treatment (CTRL RNAi and PGRMC1 RNAi treated cells) at 48 
h after RNAi treatment. Data were polled and the mean FI of the CTRL RNAi 
treated group was set at 100%. FI values of the CTRL RNAi and PGRMC1 
RNAi treatments were expressed as a percentage of the mean CTRL RNAi 
value. For image quantification of the NCL nucleolar and nucleoplasmic 230 
signals, threshold was selected by choosing a cutoff value such that all the 
nucleolar areas with an intense NCL signal within each cell. Then, the NCL 
total nuclear FI was assessed by selecting the whole nuclear area and 
calculating the integrated density of the corresponding regions of interests 
(ROI) of a total of 50 randomly selected nuclei in CTRL RNAi and PGRMC1 235 
RNAi treated cells. The NCL nucleolar signal was calculated by analyzing the 
integrated density of the threshold area in each nucleus, while the NCL 
nucleoplasmic signal was calculated by subtracting the total nucleolar FI to 
the total nuclear FI of each nucleus. Data were polled and the mean nucleolar 
and nucleoplasmic NCL FI of the CTRL RNAi treated group were set at 100%. 240 
FI values of the CTRL RNAi and PGRMC1 RNAi treatments were expressed 
as a percentage of the mean CTRL RNAi value. Background signals did not 
change significantly among treatments 
 
Statistical analysis  245 
 Experiments were run in triplicates, unless otherwise specified. All 
statistical analysis was done using Prism software (GraphPad Prism v. 6.0e, 
La Jolla, CA, USA). Data from the replicate experiments were pooled and the 
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data expressed as a mean ± SEM. Student’s t test was used to determine 
differences between two groups.  250 
 
Results 
 
PGRMC1 localization  
 Immunofluorescence analysis indicated that PGRMC1 localized to 255 
areas of the interphase nucleus that were not stained by DAPI. PGRMC1’s 
nuclear localization in bGC was the same regardless of which PGRMC1 
antibody was used (Figure 1).  However, nuclear staining for PGRMC1 with 
the Sigma Prestige antibody displayed a diffuse signal with the staining 
associated with DAPI-negative areas and only slightly more intense than that 260 
observed for the overall nucleus. In contrast, the non-DAPI stained areas 
within the nucleus were more intensely stained using the PGRMC1 antibody 
provided by Proteintech (Figure 1).  These non-DAPI stained areas typically 
correspond to areas of the interphase nucleus where the nucleoli resided.  
 265 
PGRMC1 co-localization with NCL 
 To further characterize PGRMC1 localization in the nucleus, we 
evaluated its co-localization with the nucleolar marker, nucleolin (NCL), in 
both bGC and bovine growing and fully-grown oocytes. Immunofluorescence 
data indicated that the two proteins co-localized in the nucleolus of bGC as 270 
shown in Figure 2; PGRMC1 signal appeared as a dotted pattern in the area 
corresponding to the nucleolus compared to NCL signal, which fully covered 
the nucleolus space (i.e. nuclear areas not stained by DAPI). Although co-
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localized, in situ proximity ligation assay did not detect an interaction between 
PGRMC1 and NCL, indicating the absence of a direct interaction between the 275 
two proteins in bGC (Data not shown).  
 In growing bovine oocytes, which are characterized by the presence of 
an active nucleolus (Fair et al. 1996, Lodde et al. 2008), NCL marked the 
nucleolus and showed a light diffuse staining pattern in the nucleoplasm as 
previously described (Fair et al. 2001, Baran et al. 2004, Maddox-Hyttel et al. 280 
2005). In particular, NCL nucleolar signal was intense and slightly more 
concentrated at the periphery of the nucleolus. In these oocytes PGRMC1 
localized in the nucleolus showing a dotted staining pattern, similar to that 
observed in bGC nucleoli (Figure 2). In fully-grown oocytes (Figure 2), which 
typically displayed inactive nucleolar remnants (Fair et al. 1996, Lodde et al. 285 
2008), NCL was mainly dispersed in the nucleoplasm with a faint staining in 
the nucleolar remnants as previously described (Fair et al. 2001, Baran et al. 
2004, Maddox-Hyttel et al. 2005). In these oocytes PGRMC1 concentrated in 
one or multiple dots where it co-localized with NCL. 
 290 
Assessment of PGRMC1 and nucleolin functional interaction  
 In order to establish the possible functional relationship between 
PGRMC1 and NCL, we silenced PGRMC1 expression in bGC by using RNAi. 
The RNAi protocol was previously validated by quantitative reverse 
transcriptase-polymerase chain reaction (qRT-PCR) showing a significant 295 
reduction of PGRMC1 mRNA levels compared to CTRL RNAi treated group 
(Terzaghi et al. 2016).  That PGRMC1 expression was reduced after 48h 
PGRMC1-RNAi treatment was confirmed by Western blot analysis, regardless 
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of which PGRMC1 antibody was used.  As shown in Figure 3A, PGRMC1 was 
present in multiple bands, whose intensity decreased after 48h of PGRMC1 300 
RNAi treatment. Moreover, quantification of PGRMC1 nucleolar 
immunofluorescent signal in PGRMC1 and CTRL-RNAi treated bGC revealed 
an approximate 40% decrease in PGRMC1 abundance in the nucleolus, 
which also gives confirmation of the specificity of PGRMC1’s nucleolar 
localization (Figure 3B and 3C). 305 
 In order to assess the putative functional relationship between 
PGRMC1 and NCL, the effect of depleting PGRMC1 on the localization of 
NCL was evaluated. As shown in Figure 4, when PGRMC1 was depleted, a 
significantly higher quantity of nucleolin was present in the nucleoplasm when 
compared to the CTRL-RNAi treated group.  310 
 
Discussion  
 The present findings demonstrate that PGRMC1 localizes to the 
nucleolus of both bovine granulosa cells and oocytes, suggesting that 
PGRMC1 has a role in regulating the function of the nucleolus of these two 315 
cell types.  The prominent nucleolar localization of PGRMC1 as revealed 
using the Protein Tech antibody is consistent with investigations of non-
ovarian cells that detect PGRMC1 within the nucleolus by either 
immunohistochemistry (http://www.proteinatlas.org) or mass spectrometric 
analysis (Ahmad et al. 2009, Luciano et al. 2010, Boisvert et al. 2012, Thul et 320 
al. 2017).  However, the rabbit polyclonal antibody to PGRMC1 provided by 
Sigma Prestige detects PGRMC1 not only within the nucleolus but also in 
other interchromatin regions that resemble the nuclear speckles (Spector & 
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Lamond 2011). The reason for this discord likely relates to the two antibodies 
detecting different molecular weight forms of PGRMC1. Western blots using 325 
either the Proteintech or the Sigma Prestige antibody detect PGRMC1 as 
bands at ≈ 25 and ≈ 55 kDa, while the Sigma antibody also detects an 
additional band at 37 kDA and two bands greater than 55 kDA.  All the bands 
detected by either antibody are specific since their intensity is decreased in 
PGRMC1 RNAi-treated cells.  The different size forms of PGRMC1 are due to 330 
dimerization and post-translational modifications such as phosphorylation and 
sumoylation (Neubauer et al. 2008, Peluso et al. 2010b, Peluso et al. 2012, 
Kabe et al. 2016). Therefore, it is not surprising that polyclonal antibodies 
obtained using different immunogens may preferentially recognize one or 
multiple forms of PGRMC1, which in turn might preferentially localize in 335 
different subcellular compartment. 
 Because the Proteintech antibody precisely localizes PGRMC1 to the 
nucleolus, it was used to determine whether PGRMC1 co-localizes with the 
nucleolar protein, NCL.  This approach reveals that PGRMC1 and NCL co-
localizes to the nucleolus in bGC.  Moreover, depletion of PGRMC1 results in 340 
NCL within the nucleolus redistributing to nucleoplasm in these cells. Thus, 
localization of NCL is likely dependent in part on PGRMC1. This observation 
is biologically relevant since NCL mobilization from the nucleolus into the 
nucleoplasm is induced by different types of cellular stress.  For example, 
heat shock, ionizing radiation, and hypoxia all promote the translocation of 345 
nucleolin into the nucleoplasm (Daniely & Borowiec 2000, Daniely et al. 
2002). In particular, NCL redistribution is induced by heat stress in HeLa cells 
and accompanied by an increase in the formation of a complex between NCL 
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and Replication Protein A (RPA) (Daniely & Borowiec 2000), which exerts 
important functions during DNA replication (Iftode et al. 1999).  NCL-RPA 350 
interaction in turn strongly inhibits DNA replication, likely by sequestering RPA 
away from sites of ongoing DNA synthesis (Daniely & Borowiec 2000). Other 
studies in U2-OS and U2-OS p53-depleted cells demonstrate that NCL 
redistribution occurs when stress is induced by γ-irradiation and treatment 
with the radiomimetic agent, camptothecin.  Under these stress conditions, 355 
NCL binds p53, which facilitates its transit into the nucleoplasm (Daniely et al. 
2002).  These stress-induced changes in NCL’s localization suggest that 
various stressors change PGRMC1 function, altering its ability to retain NCL, 
which allows NCL to transit to the nucleoplasm.  This concept merits further 
investigation.  360 
 Although PGRMC1 and NCL often co-localize to the same sub-region 
of the nucleolus of bGC, they do not seem to directly interact, since we were 
not able to detect a positive signal by means of PLA assay. This might 
suggest that their functional interaction could involve the participation of other 
yet to be identified protein. Interestingly a known PGRMC1 binding protein, 365 
Plasminogen Activator Inhibitor 1 RNA-Binding Protein (PAIRBP1) (Peluso et 
al. 2006, Peluso et al. 2008, Peluso et al. 2013) (also known as SERPINE1 
mRNA Binding Protein 1), which is typically found in the cytoplasm, localizes 
to the nucleolus under specific experimental stress induced conditions in Hela 
cells, such as treatment with arsenite and the methylation inhibitor adenosine 370 
periodate (Lee et al. 2014).  Therefore, it is possible that PAIRBP1 competes 
with this putative intermediary protein for binding to PGRMC1.  The stress-
induced formation of the PGRMC1: PAIRBP1 complex could potentially 
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interfere with PGRMC1’ ability to retain NCL within the nucleolus and account 
for the translocation of nucleolin from the nucleolus into the nucleoplasm 375 
under stress condition.   
 Finally, the present study reveals the relationship between PGRMC1 
and NCL in bovine oocytes.  PGRMC1 is present in the nucleolus of growing 
oocytes and the signal is retained to some extent in the nucleolar remnants of 
fully-grown bovine oocytes. During growth, the oocyte’s nucleus is 380 
characterized by the presence of a diffuse filamentous transcriptionally active 
chromatin and by a functional fibrillogranular nucleolus, which is gradually 
disassembled forming the so called ‘nucleolar remnants’, along with the 
progressive inactivation of rRNA synthesis that occurs at the end of oocyte 
growth (Fair et al. 1996, Lodde et al. 2008). Ultrastructurally, the nucleolar 385 
remnants appear as electron dense spheres often showing a semilunar 
fibrillar center-like structures attached (Fair et al. 1996, Lodde et al. 2008). In 
bovine oocytes, proteins such as RNA polymerase I and UBF remain 
associated to the inactive nucleolar remnants, while others, such as NCL and 
nucleophosmin mostly disperse in the nucleoplasm (Fair et al. 2001, Baran et 390 
al. 2004, Maddox-Hyttel et al. 2005). Upon meiotic resumption and during 
oocyte maturation the nucleolar remnant further disassembles and nucleolar 
proteins are probably dispersed in the cytoplasm. After fertilization the so 
called ‘nucleolar precursor bodies’ (NPBs) appear as electron dense compact 
spheres in the male and female pronuclei reviewed in (Maddox-Hyttel et al. 395 
2005). The NPBs serve for the re-establishment of a functional fibrillogranular 
nucleolus, which in bovine occurs at the time of major embryonic genome 
activation (at the 8-16 cell stage). It has been proposed that proteins engaged 
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in late rRNA processing of maternal origin, including NCL, are to some extent 
re-used for nucleologenesis in the embryo while others need to be de-novo 400 
transcribed before being incorporated in the nucleolus (reviewed in (Maddox-
Hyttel et al. 2005)). In this scenario, PGRMC1 localization in growing and 
fully-grown oocytes and in the NPBs of bovine zygotes (Luciano et al. 2010)  
suggests a role in both the disassembly and the reassembly of the nucleolus 
during meiosis and early embryogenesis. Interestingly, in growing oocytes (as 405 
in bGC) PGRMC1 and NCL showed a different localization pattern, with 
PGRMC1 showing a dotted localization. A similar pattern in growing bovine 
oocytes has been reported for the RNA polymerase I-specific transcription 
initiation factor, Upstream Binding Factor (UBF) (Baran et al. 2004). In future 
studies, it will be important to assess whether a specific functional interaction 410 
between NCL or other nucleolar proteins and PGRMC1 exists during early 
embryonic development and thereby influences the embryogenesis.  
  
 
 415 
 
 
 
 
 420 
Tables 
Table 1: list of antibody used 
Cell type Technique Primary antibody  Secondary 
antibody  
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Bovine 
Granulosa 
Cells (bGC) 
Immunofluorescence - Rabbit polyclonal anti-
PGRMC1 (1:50; Protein 
tech, 12990-1-AP) 
- Rabbit polyclonal anti-
PGRMC1 (1:50; Sigma, 
HPA002877) 
- Mouse monoclonal anti-
nucleolin (1:2000; Thermo 
scientific, MA1-20800) 
 
- TRITC-labeled 
donkey anti-rabbit 
(1:100; Vector 
Laboratories, Inc.) 
- Alexa Fluor 488-
labeled donkey 
anti-mouse 
(1:1000;Life 
Technologies) 
Oocytes Immunofluorescence - Rabbit polyclonal anti-
PGRMC1 (1:200; Protein 
tech, 12990-1-AP) 
- Mouse monoclonal anti-
nucleolin (1:2000; Thermo 
scientific, MA1-20800) 
 
- TRITC-labeled 
donkey anti-rabbit 
(1:100; Vector 
Laboratories, Inc.) 
- Alexa Fluor 488-
labeled donkey 
anti-mouse 
(1:1000;Life 
Technologies) 
Bovine 
Granulosa 
Cells (bGC) 
In situ proximity 
ligation assay (PLA) 
- Rabbit polyclonal anti-
PGRMC1 (Protein tech, 
12990-1-AP -1:50) 
- Mouse monoclonal anti-
nucleolin (1:2000, Thermo 
scientific, MA1-20800) 
 
Anti-rabbit PLUS 
and anti-mouse 
MINUS PLA 
probes (Duolink® 
In Situ PLA®) 
Bovine 
Granulosa 
Cells (bGC) 
Western blot - Rabbit polyclonal anti-
PGRMC1 (1:200; Protein 
tech, 12990-1-AP) 
- Rabbit polyclonal anti-
PGRMC1 (1:50; Sigma, 
HPA002877) 
- Mouse monoclonal anti- 
beta tubulin (1:1000; 
Sigma, T8328) 
 
- Goat anti rabbit 
IgG peroxidase 
conjugated 
(1:1000; Thermo 
scientific) 
 
- Goat anti mouse 
IgG peroxidase 
conjugated 
(1:1000; Thermo 
scientific) 
 
 
 425 
 
 
 
 
Figure caption 430 
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Figure 1: PGRMC1 immunofluorescent localization (red) in bGC obtained 
using SIGMA Prestige (A) and the Proteintech (B) rabbit polyclonal 
antibodies. DNA is stained with DAPI (blue). Insets show a single magnified 
nucleus. Note that both antibodies show intense staining in DAPI negative 435 
areas (arrows).  
 
Figure 2: PGRMC1 (red) and NCL (green) immunofluorescence localization in 
bGC, growing oocytes and fully-grown oocytes. DNA is stained with DAPI 
(blue). Merged images shows partial PGRMC1-nucleolin co-localization 440 
(yellow). Insets represent 3X magnification. 
 
Figure 3: Effect of PGRMC1 RNAi mediated gene silencing on PGRMC1 
expression. (A) Representative Western blotting analysis showing PGRMC1 
protein levels in PGRMC1 and CTRL-RNAi treated bGC after 48 h of 445 
treatment using the SIGMA Prestige and the Proteintech rabbit polyclonal 
antibodies. Beta tubulin was used as loading control. (B) Representative 
images showing PGRMC1 immunofluorescent staining in PGRMC1 and 
CTRL-RNAi treated bGC. (C) Graph showing analysis of PGRMC1 
immunofluorescence intensity in the nucleolus of PGRMC1 and CTRL-RNAi 450 
treated bGC after 48h of treatment; * indicates significant difference (t-test, 
p<0.05) 
 
Figure 4: Effect of PGRMC1 RNAi mediated gene silencing on NCL 
localization. (A) Representative images showing NCL immunofluorescent 455 
staining in PGRMC1 and CTRL-RNAi treated bGC; note the increased 
 20 
nucleoplasmic signal in PGRMC1 RNAi treated cell. (C) Graph showing 
analysis of PGRMC1 immunofluorescence intensity in the nucleoplasm of 
PGRMC1 and CTRL-RNAi treated bGC after 48h of treatment; * indicates 
significant difference (t-test, p<0.05) 460 
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